Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 10Terminated 3Recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 159Sarcoma 7Gastrointestinal 5Breast 4Genitourinary 3Thoracic 2Lymphoid 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Dermatologic 1Classical hematology 1

Conditions

Ovarian Neoplasms 406Uterine Cervical Neoplasms 400Endometrial Neoplasms 197Carcinoma, Ovarian Epithelial 100Breast Neoplasms 72Fallopian Tube Neoplasms 71Uterine Cervical Dysplasia 68Neoplasms 51Colorectal Neoplasms 42Pancreatic Neoplasms 40Stomach Neoplasms 39Peritoneal Neoplasms 32Papillomavirus Infections 32Recurrence 31Uterine Neoplasms 29Vulvar Neoplasms 27Prostatic Neoplasms 26Lung Neoplasms 24Esophageal Neoplasms 23Urinary Bladder Neoplasms 22Melanoma 20Colonic Neoplasms 20Head and Neck Neoplasms 19Gynecologic Cancer 19Endometrial Hyperplasia 18Neoplasm Metastasis 17Carcinoma, Non-Small-Cell Lung 17Squamous Intraepithelial Lesions 16Sarcoma 16Ovarian Cysts 15

Interventions

Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Glioma × Gynecologic × Clear all
NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Shenzhen BinDeBio Ltd.

Phase 1/2 Unknown
73 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡